| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/24/1992 | EP0490920A1 Pharmaceutical preparation binding with gastric acid. |
| 06/23/1992 | US5124342 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | US5124158 Applying 2-pyridylmethylthio- and sulfinyl-benzimidazoles |
| 06/23/1992 | US5124144 Polyethylene glycol, sodium sulfate, sodium bicarbonate, sodium and potassium chlorides, saccharin, flavoring, retains isotonicity good taste |
| 06/23/1992 | CA1304082C Benzoxazine compounds and pharmaceutical use thereof |
| 06/22/1992 | CA2058168A1 New use of peptide derivative |
| 06/22/1992 | CA2055661A1 Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation |
| 06/20/1992 | CA2057990A1 Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them |
| 06/20/1992 | CA2057959A1 Phenylalkylaminoalkyl compounds, methods for preparing them, and pharmaceutical compositions containing them |
| 06/17/1992 | EP0490772A1 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them |
| 06/17/1992 | EP0490561A2 Nutrition |
| 06/17/1992 | EP0490450A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastrointestinal medicines |
| 06/17/1992 | EP0490263A1 Alpha-oxoacetamide derivatives |
| 06/16/1992 | US5122596 Polypeptides useful as blockers of calcium channels |
| 06/16/1992 | US5122374 Pharmaceutical product having epidermal regenerative activity based on the active ingredient of mimosa tenuiflora and process for its obtention |
| 06/16/1992 | CA1303616C N-1-azabicyclo¬2,2,2|-oct-3yl)-benzamide compounds |
| 06/14/1992 | WO1992010190A1 Novel csaids |
| 06/14/1992 | CA2098177A1 Csaids |
| 06/12/1992 | WO1992010502A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines |
| 06/12/1992 | WO1992010479A1 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids with antigastrin activity |
| 06/12/1992 | CA2097069A1 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids with antigastrin activity |
| 06/12/1992 | CA2075812A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines |
| 06/12/1992 | CA2057336A1 Composition and method for preventing fluorosis |
| 06/11/1992 | WO1992009589A1 Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same |
| 06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
| 06/11/1992 | WO1992009563A1 Improved matrix metalloprotease inhibitors |
| 06/11/1992 | WO1992009553A1 Water-soluble pentacyclic triterpene composition and production thereof |
| 06/11/1992 | WO1992009272A1 Method and composition for controlled delivery of biologically active agents |
| 06/11/1992 | DE4139840A1 Compsns. contg. antigen from cell-associated protein of H. pylorus - useful for sensitive selective detection of antibodies with less false positives and negatives |
| 06/11/1992 | CA2096225A1 Matrix metalloprotease inhibitors |
| 06/10/1992 | EP0489300A2 Tetralones with pharmacological activity |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/09/1992 | US5120850 Process for the preparation of morphologically homogeneous forms of thiazole derivatives |
| 06/09/1992 | US5120539 Diarrhea therapy for infants |
| 06/09/1992 | US5120533 Treatment of ulcers of the gastrointestinal tract using dimethylpolysiloxane |
| 06/09/1992 | CA1303045C Selective inhibitors for benzylaminoxidases with respect to other aminoxidases |
| 06/09/1992 | CA1303038C Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprisingthe same |
| 06/09/1992 | CA1302892C Peptic ulcer composition containing essential fatty acids |
| 06/09/1992 | CA1302878C Agent for the regulation of the appetite or a sleeping agent |
| 06/08/1992 | CA2057181A1 Scrotonergic .alpha.-oxoacetamide |
| 06/08/1992 | CA2056957A1 Nutrition |
| 06/06/1992 | CA2056922A1 Tetralones with pharmacological activity |
| 06/05/1992 | CA2056810A1 Extract from mixture of phellodendron and seed of croton, method for the same and drug containing the same |
| 06/03/1992 | EP0488589A1 Process for producing kappa-casein glycomacropeptides |
| 06/03/1992 | EP0488513A2 Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. |
| 06/03/1992 | EP0488139A1 Pharmaceutical composition comprising calcium polycarbophil |
| 06/02/1992 | US5118714 Aqueous extract from pittosporaceae effective for treating diabetes and liver dysfunction |
| 06/02/1992 | US5118693 4,4-disubstituted piperidine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/02/1992 | CA1302266C Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems |
| 05/29/1992 | WO1992005172A3 Muscarinic receptor antagonists |
| 05/28/1992 | WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
| 05/28/1992 | CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
| 05/27/1992 | EP0487207A1 Benzolactam analogs as antagonists of CCK |
| 05/27/1992 | EP0486734A1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
| 05/27/1992 | EP0486702A1 Phenyl 4-guanidinobenzoate derivative, process for producing the same, and protease inhibitor containing the same |
| 05/27/1992 | EP0486561A1 Buccal composition containing s(+) flurbiprofen or ketoprofen. |
| 05/26/1992 | US5116857 Method of increasing gastrointestinal motility with substituted benzamides |
| 05/26/1992 | CA1301762C Dichloroaniline derivatives |
| 05/26/1992 | CA1301753C Process for preparing histamine h_-antagonist and intermediates used in such process |
| 05/24/1992 | WO1992009602A1 Pyridobenzoindole derivatives, their preparation method, and pharmaceutical compositions containing same |
| 05/24/1992 | CA2096719A1 Pyridobenzoindole derivatives, their preparation and pharmaceutical compositions containing them |
| 05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
| 05/22/1992 | WO1992009203A1 Tnf inhibitors |
| 05/22/1992 | CA2096623A1 Tnf inhibitors |
| 05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
| 05/20/1992 | EP0485962A2 New tricyclic compounds |
| 05/20/1992 | CN1016689B Method for preparation of 2,3-thiomorpholine diketone-2-oxime derivative |
| 05/19/1992 | US5114955 Derivatives with pyridine as gastrointestinal disorders and antisecretory agents |
| 05/19/1992 | US5114950 Psychological disorders, anxiety, nausea and vomiting |
| 05/17/1992 | WO1992008367A1 Compositions containing psyllium |
| 05/17/1992 | CA2055680A1 Tricyclic compounds |
| 05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
| 05/14/1992 | DE4036140A1 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel 9-halo-11ß-hydroxy-prostaglandin derivatives, to processes for their preparation and their use as medicaments |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/13/1992 | EP0485173A2 Esters and amides of substituted fused ring phenyl acetic acids |
| 05/13/1992 | EP0485172A2 Esters and amides of substituted indenyl acetic acids |
| 05/13/1992 | EP0485158A2 Esters and amides of substituted phenyl acetic acids |
| 05/13/1992 | EP0485157A2 Esters and amides of substituted pyrrole acetic acids |
| 05/12/1992 | US5112872 Antispasmodic agent |
| 05/12/1992 | US5112866 Sulfonylfluorides as intermediates, also useful in treatment of bone disorders, antisecretory, antiulcer |
| 05/12/1992 | US5112850 Drug for treatment of gastric and duodenal peptic ulcer disease |
| 05/12/1992 | US5112834 Antisecretory and antiulcer |
| 05/12/1992 | US5112826 Cardiovascular disorders |
| 05/12/1992 | US5112822 Gastrointestinal disorders and glaucoma treatment |
| 05/12/1992 | CA1300625C 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-[1]benzothieno [3,2-e]-1,2-thiazine-4-carboxamide-1,1-dioxides |
| 05/10/1992 | WO1992008697A2 9-HALOGEN-11β-HYDROXY PROSTAGLANDIN DERIVATIVE, PROCESS FOR PRODUCING IT AND ITS USE AS A MEDICAMENT |
| 05/10/1992 | CA2073462A1 9-halogen-11beta-hydroxy-prostaglandin derivatives, process for their production and their use as pharmaceutical agents |
| 05/06/1992 | EP0484266A2 Fat mixture for infant and adult nutrition |
| 05/06/1992 | EP0484148A1 A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483928A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use |
| 05/06/1992 | EP0472588A4 Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
| 05/06/1992 | EP0313654B1 Drug for prophylaxis and treatment of hepatopathy |
| 05/05/1992 | US5110925 Cardiotonic agents |
| 05/05/1992 | CA1300162C2 Benzamide, preparation process and therapeutic use |
| 05/05/1992 | CA1300154C N-substituted piperid-4-yl benzamide compounds and 1-substituted-4-amino-piperidine compounds |
| 05/05/1992 | CA1300153C 2-pyridylacetic acid derivative, preparation process thereof and pharmaceutical composition containing the same |
| 05/05/1992 | CA1300133C Benzimidazolesulfonamides and imidazopyridinesulfonamides; process for preparing the same and their use as therapeutic agents |